UnitedHealth Group (NYSE: UNH) recently reported its Q3 results, with revenues and earnings exceeding our expectations.
I discuss and analyze UNH's cautious FY2025 guidance, attributing lower bottom-line to various factors. Click here to read my ...
Investor's Business Daily on MSN5d
UNH Stock Inflicts 350-Point Hit On Dow Jones As High Costs Weigh On OutlookUnitedHealth Group beat third-quarter earnings forecasts but lowered the top range of its full-year outlook and reined in expectations for 2025 amid challenges with Medicare Advantage utilization and ...
Oppenheimer analyst Michael Wiederhorn maintained a Buy rating on UnitedHealth (UNH – Research Report) today and set a price target of ...
Shares of UnitedHealth Group tumbled Tuesday as the company lowered its full-year outlook to reflect the impact of a February ...
UNH, CI, HUM and MOH are likely to navigate industry ... that the majority of the unknowns have been cleared up, views the stock selloff as overdone, and would use it as an opportunity to buy ...
UnitedHealth's lower 2025 earnings outlook than expected leads to a sell-off, affecting its managed care rivals like ...
The UNH stock performance is affected by management’s full-year 2024 outlook of $15.50 to $15.75 per share in net income, ...
Quarterly profit of $6.06 billion at the Minnetonka-based company beat analyst estimates on a per-share basis as revenue grew ...
We recently compiled a list of the Jim Cramer is Talking About These 14 Stocks Before Earnings. In this article, we are going ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback